Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of SEVENFACT® for the Treatment of Bleeding Events in Patients With Hemophilia A or B With Inhibitors

NCT04647227 is registered in ClinicalTrials.gov with American Thrombosis and Hemostasis Network as lead sponsor.

NCT NCT04647227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04647227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of SEVENFACT® for the Treatment of Bleeding Events in Patients With Hemophilia A or B With Inhibitors
Lead sponsor
American Thrombosis and Hemostasis Network
Phase
Phase 4
Overall status
Recruiting
Start date
June 28, 2021
Completion date
March 31, 2027
Enrollment
55 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a with inhibitor, hemophilia b with inhibitor